Dyslipidemia and the Treatment of Lipid Disorders in African Americans

American Journal of Medicine

Volumn 122, Issue 5, 2009, Pages 454-463

  Taylor Jr , Herman A ^a,b,c   Akylbekova, Ermeg L ^b   Garrison, Robert J ^a   Sarpong, Daniel ^b   Joe, Jennifer ^d   Walker, Evelyn ^e   Wyatt, Sharon B ^a   Steffes, Michael W ^f  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b JACKSON STATE UNIVERSITY   (United States)

^c TOUGALOO COLLEGE   (United States)

^d GEORGETOWN UNIVERSITY HOSPITAL   (United States)

^e NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^f UNIVERSITY OF MINNESOTA   (United States)

Author keywords

African Americans; Cardiovascular disease; Cholesterol; Dyslipidemia; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; AWARENESS; CONTROLLED STUDY; DISORDERS OF LIPID AND LIPOPROTEIN METABOLISM; DYSLIPIDEMIA; FEMALE; HEALTH SURVEY; HUMAN; HYPERCHOLESTEROLEMIA; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SELF REPORT;

ADULT; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ANTILIPEMIC AGENTS; DYSLIPIDEMIAS; FEMALE; HUMANS; MALE; MIDDLE AGED; MISSISSIPPI; PREVALENCE; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; YOUNG ADULT;

EID: 59249105909     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2008.09.049     Document Type: Article

References (44)

1. Taylor Jr. H.A., Wilson J.G., Jones D.W., et al. Toward resolution of cardiovascular health disparities in African Americans: design and methods of the Jackson Heart Study. Ethn Dis 15 4 Suppl 6 (2005) S6-S17
2. Langford H.G., Oberman A., Borhani N.O., et al. Black-white comparison of indices of coronary heart disease and myocardial infarction in the stepped-care cohort of the Hypertension Detection and Follow-Up Program. Am Heart J 108 3 Pt 2 (1984) 797-801
3. Jones D.W., Chambless L.E., Folsom A.R., et al. Risk factors for coronary heart disease in African Americans: the atherosclerosis risk in communities study, 1987-1997. Arch Intern Med 162 (2002) 2565-2571
4. Gillum R.F., Mussolino M.E., and Madans J.H. Coronary heart disease risk factors and attributable risks in African-American women and men: NHANES I epidemiologic follow-up study. Am J Public Health 88 (1998) 913-917
5. Gillum R.F., Mussolino M.E., and Sempos C.T. Baseline serum total cholesterol and coronary heart disease incidence in African-American women (the NHANES I epidemiologic follow-up study). National Health and Nutrition Examination Survey. Am J Cardiol 81 (1998) 1246-1249
6. Vermaak W.J., Ubbink J.B., Delport R., et al. Ethnic immunity to coronary heart disease?. Atherosclerosis 89 (1991) 155-162
7. Keil J.E., Sutherland S.E., Hames C.G., et al. Coronary disease mortality and risk factors in black and white men. Results from the combined Charleston, SC, and Evans County, Georgia, heart studies. Arch Intern Med 155 (1995) 1521-1527
8. Harris-Hooker S., and Sanford G.L. Lipids, lipoproteins and coronary heart disease in minority populations. Atherosclerosis 108 Suppl (1994) S83-S104
9. Paultre F., Tuck C.H., Boden-Albala B., et al. Relation of Apo(a) size to carotid atherosclerosis in an elderly multiethnic population. Arterioscler Thromb Vasc Biol 22 (2002) 141-146
10. Paultre F., Pearson T.A., Weil H.F., et al. High levels of Lp(a) with a small apo(a) isoform are associated with coronary artery disease in African American and white men. Arterioscler Thromb Vasc Biol 20 (2000) 2619-2624
11. Budoff M.J., Nasir K., Mao S., et al. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis 187 (2006) 343-350
12. Benton J.L., Blumenthal R.S., Becker D.M., et al. Predictors of low-density lipoprotein particle size in a high-risk African-American population. Am J Cardiol 95 (2005) 1320-1323
13. Metcalf P.A., Sharrett A.R., Folsom A.R., et al. African American-white differences in lipids, lipoproteins, and apolipoproteins, by educational attainment, among middle-aged adults: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 148 (1998) 750-760
14. Murtaugh K.H., Borde-Perry W.C., Campbell K.L., et al. Obesity, smoking, and multiple cardiovascular risk factors in young adult African Americans. Ethn Dis 12 (2002) 331-335
15. Rodriguez C., Pablos-Mendez A., Palmas W., et al. Comparison of modifiable determinants of lipids and lipoprotein levels among African-Americans, Hispanics, and Non-Hispanic Caucasians > or =65 years of age living in New York City. Am J Cardiol 89 (2002) 178-183
16. Massing M.W., Foley K.A., Carter-Edwards L., et al. Disparities in lipid management for African Americans and Caucasians with coronary artery disease: a national cross-sectional study. BMC Cardiovasc Disord 4 (2004) 15
17. O'Meara J.G., Kardia S.L., Armon J.J., et al. Ethnic and sex differences in the prevalence, treatment, and control of dyslipidemia among hypertensive adults in the GENOA study. Arch Intern Med 164 (2004) 1313-1318
18. Clark L.T., Maki K.C., Galant R., et al. Ethnic differences in achievement of cholesterol treatment goals. Results from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology II. J Gen Intern Med 21 (2006) 320-326
19. Simon J.A., Lin F., Hulley S.B., et al. Phenotypic predictors of response to simvastatin therapy among African-Americans and Caucasians: the Cholesterol and Pharmacogenetics (CAP) Study. Am J Cardiol 97 (2006) 843-850
20. Persell S.D., Maviglia S.M., Bates D.W., and Ayanian J.Z. Ambulatory hypercholesterolemia management in patients with atherosclerosis. Gender and race differences in processes and outcomes. J Gen Intern Med 20 (2005) 123-130
21. Carpenter M.A., Crow R., Steffes M., et al. Laboratory, reading center, and coordinating center data management methods in the Jackson Heart Study. Am J Med Sci 328 (2004) 131-144
22. Fuqua S.R., Wyatt S.B., Andrew M.E., et al. Recruiting African-American research participation in the Jackson Heart Study: methods, response rates, and sample description. Ethn Dis 15 4 Suppl 6 (2005) S6-S29
23. The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators. Am J Epidemiol 129 (1989) 687-702
24. Wilson J.G., Rotimi C.N., Ekunwe L., et al. Study design for genetic analysis in the Jackson Heart Study. Ethn Dis 15 4 Suppl 6 (2005) S6-S37
25. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
26. Sketris I.S., Metge C.J., Ross J.L., and MacCara M.E. The use of the World Health Organization anatomical therapeutic chemical/defined daily dose methodology in Canada. Drug Info J 38 (2004) 1-8
27. Standards of medical care in diabetes. Diabetes Care 27 Suppl 1 (2004) S15-S35
28. Manolio T.A., Cushman M., Gottdiener J.S., et al. Predictors of falling cholesterol levels in older adults: the Cardiovascular Health Study. Ann Epidemiol 14 (2004) 325-331
29. Levey A.S., Coresh J., Balk E., et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med 139 (2003) 137-147
30. Levey A.S., Bosch J.P., Lewis J.B., et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130 (1999) 461-470
31. Taylor H., Liu J., Wilson G., et al. Distinct component profiles and high risk among African Americans with metabolic syndrome: the Jackson Heart Study. Diabetes Care 31 (2008) 1248-1253
32. Goff Jr. D.C., Bertoni A.G., Kramer H., et al. Dyslipidemia prevalence, treatment, and control in the Multi-Ethnic Study of Atherosclerosis (MESA): gender, ethnicity, and coronary artery calcium. Circulation 11 (2006) 647-656
33. Sumner A.E., Vega G.L., Genovese D.J., et al. Normal triglyceride levels despite insulin resistance in African Americans: role of lipoprotein lipase. Metabolism 54 (2005) 902-909
34. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). JAMA 269 (1993) 3015-3023
35. Muntner P., DeSalvo K.B., Wildman R.P., et al. Trends in the prevalence, awareness, treatment, and control of cardiovascular disease risk factors among noninstitutionalized patients with a history of myocardial infarction and stroke. Am J Epidemiol 163 (2006) 913-920
36. Kaplan R.C., Bhalodkar N.C., Brown D.L., et al. Differences by age and race/ethnicity in knowledge about hypercholesterolemia. Cardiol Rev 14 (2006) 1-6
37. Hendrix K.H., Riehle J.E., and Egan B.M. Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients. Ethn Dis 15 (2005) 11-16
38. Landray M.J., Thambyrajah J., McGlynn F.J., et al. Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment. Am J Kidney Dis 38 (2001) 537-546
39. Wheeler D.C., Townend J.N., and Landray M.J. Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study. Kidney Int (2003) S201-S203 Suppl
40. Garg A.X., Clark W.F., Haynes R.B., and House A.A. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int 61 (2002) 1486-1494
41. Manttari M., Tiula E., Alikoski T., and Manninen V. Effects of hypertension and dyslipidemia on the decline in renal function. Hypertension 26 (1995) 670-675
42. Trevisan R., Dodesini A.R., and Lepore G. Lipids and renal disease. J Am Soc Nephrol 17 4 Suppl 2 (2006) S145-S147
43. Ferdinand K.C., Clark L.T., Watson K.E., et al. Comparison of efficacy and safety of rosuvastatin versus atorvastatin in African-American patients in a six-week trial. Am J Cardiol 97 (2006) 229-235
44. Mensah G.A., Mokdad A.H., Ford E.S., et al. State of disparities in cardiovascular health in the United States. Circulation 111 (2005) 1233-1241